{
  "trial_id": "NCT04233801",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, BMI, duration of diabetes, baseline HbA1c, fasting C-peptide, insulin dose, use of oral antidiabetic drugs (OADs), eGFR, history of severe hypoglycemia, history of cardiovascular events, baseline fasting glucose levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated haemoglobin A1c (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Time since diagnosis of diabetes",
          "duration of diabetes"
        ],
        [
          "Background antidiabetic treatment",
          "use of oral antidiabetic drugs (OADs)"
        ],
        [
          "Type of insulin",
          "insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "BMI",
        "fasting C-peptide",
        "eGFR",
        "history of severe hypoglycemia",
        "history of cardiovascular events",
        "baseline fasting glucose levels"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Fasting C-peptide, Type of Insulin Therapy, Daily Insulin Dose, Use of Oral Antidiabetic Drugs (OADs), Estimated Glomerular Filtration Rate (eGFR),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Background antidiabetic treatment",
          "Use of Oral Antidiabetic Drugs (OADs)"
        ],
        [
          "Type of insulin",
          "Type of Insulin Therapy"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Time since diagnosis of diabetes"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "Fasting C-peptide",
        "Daily Insulin Dose",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Diagnosis Duration, Insulin Dose, HbA1c, BMI, Fasting C-peptide, eGFR, History of Hypoglycemia, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin A1c (HbA1c)",
          "HbA1c"
        ],
        [
          "Background antidiabetic treatment",
          "Insulin Dose"
        ],
        [
          "Type of insulin",
          "Type of insulin"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Time since diagnosis of diabetes"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes Diagnosis Duration",
        "BMI",
        "Fasting C-peptide",
        "eGFR",
        "History of Hypoglycemia",
        "History of Cardiovascular Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, BMI, duration of diabetes, type of insulin used, dose of insulin, use of OADs, HbA1c, fasting C-peptide, eGFR, systolic blood pressure, diastolic blood pressure, heart rate, medical history (including history of myocardial infarction, stroke, or transient ischaemic attack), smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated haemoglobin A1c (HbA1c)",
          "HbA1c"
        ],
        [
          "Background antidiabetic treatment",
          "use of OADs"
        ],
        [
          "Type of insulin",
          "type of insulin used"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Time since diagnosis of diabetes"
      ],
      "remaining_candidate_features": [
        "BMI",
        "duration of diabetes",
        "dose of insulin",
        "fasting C-peptide",
        "eGFR",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "medical history (including history of myocardial infarction, stroke, or transient ischaemic attack)",
        "smoking status"
      ]
    }
  }
}